Thyrocare Technologies Limited (NSE:THYROCARE)
India · Delayed Price · Currency is INR 492.10
+6.80 (1.40%)
Nov 11, 2026, 1:30 PM IST
Thyrocare Technologies Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 9,303 | 8,290 | 6,874 | 5,719 | 5,267 | 5,889 |
Other Revenue | - | - | - | 0.1 | - | - |
| 9,303 | 8,290 | 6,874 | 5,719 | 5,267 | 5,889 | |
Revenue Growth | 21.98% | 20.61% | 20.19% | 8.59% | -10.56% | 19.05% |
Cost of Revenue | 4,163 | 3,814 | 3,419 | 2,964 | 2,844 | 2,419 |
Gross Profit | 5,140 | 4,477 | 3,454 | 2,755 | 2,423 | 3,469 |
Selling, General & Admin | 292.5 | 292.5 | 212.2 | 208.9 | 120.5 | 83 |
Other Operating Expenses | 1,696 | 1,406 | 1,333 | 1,159 | 1,093 | 1,038 |
Operating Expenses | 2,759 | 2,439 | 2,102 | 1,838 | 1,601 | 1,459 |
Operating Income | 2,381 | 2,038 | 1,352 | 917.1 | 821.9 | 2,010 |
Interest Expense | -43.5 | -28 | -30.7 | -42 | -23.5 | -23.7 |
Interest & Investment Income | 34 | 34 | 51 | 27.1 | 13.8 | 7.1 |
Earnings From Equity Investments | 23.7 | 13.9 | -14.4 | 3.9 | 11.8 | -1.8 |
Currency Exchange Gain (Loss) | -0.3 | -0.3 | 1.5 | 0.1 | - | - |
Other Non Operating Income (Expenses) | 15.4 | 14.6 | 6.9 | 5.1 | 3.9 | 18 |
EBT Excluding Unusual Items | 2,411 | 2,072 | 1,366 | 911.3 | 827.9 | 2,010 |
Merger & Restructuring Charges | -19.6 | -19.6 | - | - | - | - |
Gain (Loss) on Sale of Investments | 77.1 | 77.1 | 88.1 | 57.8 | 53.7 | 52.2 |
Gain (Loss) on Sale of Assets | 40.8 | 40.8 | 0.1 | -9.3 | 4.3 | 215.2 |
Other Unusual Items | -491.2 | -41.4 | - | - | - | - |
Pretax Income | 2,018 | 2,129 | 1,454 | 959.8 | 885.9 | 2,277 |
Income Tax Expense | 584.6 | 500.3 | 546.9 | 264.9 | 242.3 | 515.8 |
Earnings From Continuing Operations | 1,433 | 1,629 | 907.5 | 694.9 | 643.6 | 1,761 |
Minority Interest in Earnings | 9 | 1.9 | 7.6 | 12.7 | 1.3 | - |
Net Income | 1,442 | 1,630 | 915.1 | 707.6 | 644.9 | 1,761 |
Net Income to Common | 1,442 | 1,630 | 915.1 | 707.6 | 644.9 | 1,761 |
Net Income Growth | 13.02% | 78.17% | 29.32% | 9.72% | -63.39% | 55.67% |
Shares Outstanding (Basic) | 160 | 159 | 159 | 159 | 159 | 159 |
Shares Outstanding (Diluted) | 161 | 160 | 160 | 159 | 159 | 159 |
Shares Change | 1.46% | 0.05% | 0.27% | 0.06% | 0.05% | 0.06% |
EPS (Basic) | 9.00 | 10.24 | 5.75 | 4.46 | 4.06 | 11.10 |
EPS (Diluted) | 8.96 | 10.21 | 5.74 | 4.45 | 4.06 | 11.08 |
EPS Growth | 11.39% | 78.08% | 28.98% | 9.65% | -63.41% | 55.59% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 1,807 | 1,924 | 1,464 | 1,061 | 856.6 | 755.8 |
Free Cash Flow Per Share | 11.22 | 12.05 | 9.18 | 6.67 | 5.39 | 4.75 |
Dividend Per Share | 6.997 | 9.330 | 7.000 | 6.000 | 6.000 | 5.000 |
Dividend Growth | - | 33.29% | 16.67% | 0% | 20.00% | -40.00% |
Gross Margin | 55.25% | 54.00% | 50.26% | 48.17% | 46.00% | 58.92% |
Operating Margin | 25.60% | 24.58% | 19.67% | 16.04% | 15.61% | 34.14% |
Profit Margin | 15.50% | 19.67% | 13.31% | 12.37% | 12.25% | 29.91% |
Free Cash Flow Margin | 19.42% | 23.20% | 21.30% | 18.54% | 16.26% | 12.83% |
EBITDA | 2,804 | 2,430 | 1,747 | 1,301 | 1,136 | 2,292 |
EBITDA Margin | 30.14% | 29.31% | 25.42% | 22.75% | 21.56% | 38.93% |
D&A For EBITDA | 423.2 | 392.3 | 395.3 | 383.9 | 313.8 | 282.1 |
EBIT | 2,381 | 2,038 | 1,352 | 917.1 | 821.9 | 2,010 |
EBIT Margin | 25.60% | 24.58% | 19.67% | 16.04% | 15.61% | 34.14% |
Effective Tax Rate | 28.98% | 23.50% | 37.60% | 27.60% | 27.35% | 22.65% |
Revenue as Reported | 9,474 | 8,460 | 7,022 | 5,813 | 5,351 | 6,181 |
Advertising Expenses | - | 274.7 | 194.1 | 167.4 | 64.4 | 53 |